BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kennedy NA, Hansen R, Younge L, Mawdsley J, Beattie RM, Din S, Lamb CA, Smith PJ, Selinger C, Limdi J, Iqbal TH, Lobo A, Cooney R, Brain O, Gaya DR, Murray C, Pollok R, Kent A, Raine T, Bhala N, Lindsay JO, Irving PM, Lees CW, Sebastian S. Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic. Frontline Gastroenterol 2020;11:343-50. [PMID: 32874484 DOI: 10.1136/flgastro-2020-101520] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharma E, Meade S, D'Errico F, Pavlidis P, Luber R, Zeki S, Hill K, Duff A, O'Hanlon D, Tripoli S, Stanton A, Caracostea A, Honap S, Reynolds R, Anderson S, Ray S, Mawdsley J, Sanderson J, Samaan MA, Irving PM. The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre. GastroHep 2020;2:318-26. [PMID: 33362435 DOI: 10.1002/ygh2.433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Rosiou K, Ong Ming San E, Kumar A, Esquivel K, Almas S, Stokes D, Ng T, Jayasooriya N, Ranasinghe I, Pollok R, Brookes M, Selinger CP. Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study. J Clin Med 2021;10:4329. [PMID: 34640345 DOI: 10.3390/jcm10194329] [Reference Citation Analysis]
3 Gonzalez HA, Myers S, Whitehead E, Pattinson A, Stamp K, Turnbull J, Fory R, Featherstone B, Wilkinson A, Lisle J, Haire G, Henderson E, Sebastia S. React, reset and restore: Adaptation of a large inflammatory bowel disease service during COVID-19 pandemic. Clin Med (Lond) 2020;20:e183-8. [PMID: 32719036 DOI: 10.7861/clinmed.2020-0369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kroma RB, Giordano NA, Highland KB, Bedocs P, McDuffie M, Buckenmaier CC. Implementation of the Uniformed Services University Pain Registry Biobank: A Military and Veteran Population Focused Biobank and Registry. Pain Med 2021:pnab166. [PMID: 33983447 DOI: 10.1093/pm/pnab166] [Reference Citation Analysis]
5 Avery P. Using e-health tools and PROMs to support self-management in patients with inflammatory bowel disease. Br J Nurs 2021;30:394-402. [PMID: 33830794 DOI: 10.12968/bjon.2021.30.7.394] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sebastian S, Walker GJ, Kennedy NA, Conley TE, Patel KV, Subramanian S, Kent AJ, Segal JP, Brookes MJ, Bhala N, Gonzalez HA, Hicks LC, Mehta SJ, Lamb CA;  PROTECT-ASUC Study Group. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021;6:271-281. [PMID: 33545083 DOI: 10.1016/s2468-1253(21)00016-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Tavabie OD, Clough J. Gastroenterology 2021: from the heart of the COVID-19 pandemic. Frontline Gastroenterol 2021;12:249-51. [PMID: 33907619 DOI: 10.1136/flgastro-2021-101799] [Reference Citation Analysis]
8 Maclean A, Ashton JJ, Garrick V, Beattie RM, Hansen R. Impact of COVID-19 on the diagnosis, assessment and management of children with inflammatory bowel disease in the UK: implications for practice. BMJ Paediatr Open 2020;4:e000786. [PMID: 34192173 DOI: 10.1136/bmjpo-2020-000786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 El Ouali S, Rubin DT, Cohen BL, Regueiro MD, Rieder F. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic. Curr Opin Gastroenterol 2021;37:313-9. [PMID: 33859104 DOI: 10.1097/MOG.0000000000000741] [Reference Citation Analysis]
10 Kenney MO, Becerra B, Beatty SA, Smith W. Letter to the Editor: Physicians' Opinions of COVID-19 Ambulatory Care Constraints: A Survey of Sickle Cell Clinicians. J Ambul Care Manage 2021;44:325-30. [PMID: 34120124 DOI: 10.1097/JAC.0000000000000386] [Reference Citation Analysis]
11 Jere M, Garrick V, Curtis L, Tayler R, Gervais L, Gerasimidis K, Hansen R. Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic. BMJ Open Gastroenterol 2021;8:e000631. [PMID: 33947712 DOI: 10.1136/bmjgast-2021-000631] [Reference Citation Analysis]
12 Lee G, Kammermeier J, Vora R, Mutalib M. Review of a paediatric inflammatory bowel disease service during the pandemic and the impact of the CNS role. Br J Nurs 2021;30:840-4. [PMID: 34288747 DOI: 10.12968/bjon.2021.30.14.840] [Reference Citation Analysis]
13 Mir N, Cheesbrough J, Troth T, Hussain N, Hopkins LJ, Shi J, Sarker N, Smith E, Courtney F, Flaherty J, Hill R, Jebb S, Kakosa V, Calderwood J, Sharma N, McCulloch A, Quraishi MN. COVID-19-related health anxieties and impact of specific interventions in patients with inflammatory bowel disease in the UK. Frontline Gastroenterol 2021;12:200-6. [PMID: 33903816 DOI: 10.1136/flgastro-2020-101633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Anjum MR, Chalmers J, Hamid R, Rajoriya N. COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future. World J Gastroenterol 2021; 27(44): 7625-7648 [PMID: 34908803 DOI: 10.3748/wjg.v27.i44.7625] [Reference Citation Analysis]
15 Schreiber S, Ben-Horin S, Alten R, Westhovens R, Peyrin-Biroulet L, Danese S, Hibi T, Takeuchi K, Magro F, An Y, Kim DH, Yoon S, Reinisch W. Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era. Adv Ther 2022. [PMID: 34988877 DOI: 10.1007/s12325-021-01990-6] [Reference Citation Analysis]
16 Viola A, Giambò F, Chiappetta MF, Costantino G, Pallio S, Fries W. Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic. Dig Liver Dis 2021;53:689-90. [PMID: 33832871 DOI: 10.1016/j.dld.2021.03.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Din S, Gaya D, Kammermeier J, Lamb CA, Macdonald J, Moran G, Parkes G, Pollok R, Sebastian S, Segal J, Selinger C, Smith PJ, Steed H, Arnott ID. Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic. Frontline Gastroenterol 2022;13:77-81. [PMID: 34966535 DOI: 10.1136/flgastro-2021-101805] [Reference Citation Analysis]